Trials / Completed
CompletedNCT04973020
A Drug-drug Interaction Study of SHR6390 on Healthy Chinese Volunteers
A Single-centre, Single-dose, Open-label and Self-control Study to Evaluate the Effect of Efavirenz on Pharmacokinetic of SHR6390 in Healthy Chinese Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The study is a single-center, open, single-dose, self-controlled clinical trial. It is planned to enroll 20 healthy adult subjects.Subjects will take the SHR6390 on Day1 and Day22 , and from Day8 to Day26 take the efavirenz.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR6390、efavirenz | SHR6390 tablet single dose；Efavirenz single dose. |
Timeline
- Start date
- 2021-09-01
- Primary completion
- 2021-10-28
- Completion
- 2021-10-28
- First posted
- 2021-07-22
- Last updated
- 2021-11-29
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04973020. Inclusion in this directory is not an endorsement.